Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on the FDA’s ‘Fit-for-Purpose Rare…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’“Today’s announcement is an important step…
BIO Statement on Finalization of the Globe Model
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the finalization of the GLOBE model.“Biotechnology is one of America's greatest strengths, delivering…
Nevada Governor Joe Lombardo Named BIO’s Governor…
WASHINGTON, DC (August 31, 2026) – Today, the Biotechnology Innovation Organization (BIO) awarded Nevada Governor Joe Lombardo with its 2026 Governor of the Year Award, recognizing his leadership in growing the life sciences in Nevada and commitment…
All Press Releases
  • Show All
Search
Results
Event Tags
May 20, 2019
The Biotechnology Innovation Organization (BIO) today announced that former U.S. Department of Agriculture (USDA) Secretary and former two-term Governor of Iowa Tom Vilsack will receive the 12th annual George Washington Carver Award for Innovation…
May 17, 2019
Washington, DC (May 17, 2019) – The Biotechnology Innovation Organization (BIO) today applauds the Senate passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act (S. 1379). The legislation would re-authorize…
May 14, 2019
Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases Volume IV: Alzheimer’s Disease Therapeutics, the fourth in a series on the innovation landscape of highly…
May 8, 2019
Washington, D.C. (May 8, 2019) – The Biotechnology Innovation Organization (BIO) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical companies in…
May 7, 2019
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood today expressed support for a U.S. House of Representatives letter, authored by Representatives Cindy Axne (D-Iowa) and Adrian Smith (R-Neb.), requesting U.S. Environmental…
April 29, 2019
The Biotechnology Innovation Organization (BIO) today announced that Chairman and CEO of JPMorgan Chase & Co., Jamie Dimon – a leader in the banking industry and catalyst for innovation across American business, including the healthcare industry…
April 29, 2019
The Biotechnology Innovation Organization (BIO) today submitted comments supportive of the U.S. Environmental Protection Agency’s (EPA) “Proposed Rulemaking for Modifications to Fuel Regulations to Provide Flexibility for E15 and to…
April 16, 2019
Washington, D.C. (April 16, 2019) – The Biotechnology Innovation Organization (BIO) announced today the “Right Mix Matters” campaign to increase diversity and inclusion in the biotech industry. Following on its previously announced goals to increase…
April 14, 2019
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood today applauded a Senate letter authored by Senator Tina Smith (D-Minn.) and a House letter authored by Representatives Angie Craig (D-Minn.) and Mike Bost (R-Ill.)…
April 3, 2019
Washington, D.C. (April 3, 2019) – The Biotechnology Innovation Organization (BIO) today announced Senator Pat Roberts (R-KS) will be presented with a Lifetime Achievement Award. Senator Roberts will receive the award tonight in conjunction with BIO…